Abstract
Omega-3 polyunsaturated fatty acids have been shown to decrease inflammatory markers such as TNFα, IL-1s and IL-6 levels. It has been shown that there is association between several markers of inflammation with cardiovascular disease which is the leading cause of death in the end stage of renal disease (ESRD) patients. So it may be useful to administer this supplement in renal transplant recipients. To investigate this possibility, we studied the effect of omega-3 on the occurrence of acute rejection. In this study, we assessed the effect of 6 months of dietary supplementation with 6 g/day of omega-3 fatty acids on Lipid profile (TG, HDL-C, and LDL-C) and serum concentration of TNF-, IL-6 and hs-CRP in renal transplant recipients. Based on these data, omega-3 fatty acids supplementation does not cause a decrease in serum level of tested inflammatory biomarkers in renal transplant recipients but decreases total cholesterol level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
